Newsletter Login

Username:

Password:

Forget your login?

Free
30 Day Trial!

Activate Trial

Welcome to Dow Theory Forecasts

Dow Theory Forecasts is written with the busy reader in mind. Weekly stock recommendations and analysis is geared towards the individual investor looking for actionable stock market advice in a "just-the-facts" approach. Twice weekly hotlines with market news, stock upgrades and downgrades keep subscribers informed between issues.

View back issues in the Dow Theory Archive.

From the Current Newsletter:

Feel the electricity, but don't drink the water

As a group, utilities look pretty good.

The 80 stocks in our Utility Update average Quadrix Overall scores of 60 and Value scores of 78, high relative to historical norms. But that doesn’t mean every utility is fair game. As the chart shows, industry groups within the utility sector have delivered drastically divergent returns in recent years. Don’t expect them to move...

Read the rest of this article for more specific investing advice and stock investment information when you sign up for a FREE 30-day trial to Dow Theory Forecasts.


More Investment Newsletters and Services

Drip Investor

DRIP Investor — how you can buy dividend-paying stocks without a broker.

Visit us at DRIP Investor, your source for dividend reinvestment plans.

Lazy Investor

The Lazy Investor — free weekly e-letter that delivers market updates and stock market information via email.

Visit us at The Lazy Investor, our free investment newsletter.

Horizon Investment

Horizon — registered investment advisor seeks to provide investors at all stages the ability to build, preserve and enjoy wealth.

Visit us at Horizon Investment Services to get started in an investment program that's right for you.

Upside

Upside — discovers today's small and midcap stocks poised to be tomorrow's Blue Chip leaders.

Visit us at Upside, your guide to the best buys in small and midcap stocks.

Current Hotline

Friday, February 5, 2010


Hit by worries about the global economy, the Dow Industrials suffered their worst one-day decline since April. After further weakness this morning…

Read More from the Hotline

Stock Spotlight

Hospira finds healthy niche

Wednesday, February 3, 2010

Abbott Laboratories ($54; ABT) spun off its hospital-supply unit, also known as Hospira ($52; HSP), in 2004. Now, Hospira stands as one of the few unqualified winners as U.S. health-reform efforts...

Read More from Stock Spotlight

Individual Stock Reports

ISRs make stock research easy!

Perhaps the most valuable two page reports available anywhere.

All the data you would normally have to plow through years of 10-K filings, earnings reports, and reams of market data to assemble — yours all in one concise report.

ISRs contain our proprietary Quadrix scores — find out how we rate all the stocks in the S&P 500.

Visit us at individualstockreports.com